| Company | Viz.ai |
| Fund Raised | $100 Million |
| Investor | Insight Partners & Tiger Global |
| Co-Founder/CEO | Chris Mansi |
| Profile | https://www.linkedin.com/company/viz.ai |
Viz.ai Raised $100M in Series D for Expansion
Viz.ai, and Tel Aviv an AI based diseases detection platform raised $100 million led by Insight Partners & Tiger Global in series D at an unbelievable valuation of $1.2 billion.
Also, read Beep 25M Series Capital 50MSoderstrom Orlando
CEO Chris said that we use these funds to upgrade our AI to detect additional data. Our AI is connected to the server and can check the diseases with their history.
Viz.AI is vascular and neurovascular clinically approved AI used by specialist doctors around the globe and we will expand our market size soon.
